Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Figure out How to Introduce Sunlight powered chargers on Your Rooftop securely - 2A whale stranded at a Baltic Sea resort has swum off a sandbank. But it isn't safe yet
- 3Most loved Specially prepared Espresso Mix: Which Meal Do You Adore the Most?
- 4To fix a patient's irregular heartbeat, doctors first tested its digital 'twin'
- 5A few Up-to-date Sacks - Stylish Young ladies Shouldn't Miss
- Amazon sued over 'punitive' handling of employee absences
- Barry Manilow reveals lung cancer diagnosis and plans to undergo surgery: 'It's pure luck' it was 'found so early'
- Russian strikes on Ukraine kill 5 people and wound 30 more
- Hezbollah fires over 600 times at Israel, IDF troops over last 24 hours
- Euclid space telescope sees gorgeous cosmic cloud | Space photo of the day for Nov. 18, 2025
- Millions in JDM Exports and Exotic Supercars Are Currently Trapped at Sea
- 3 back-to-back storms forecast to bring snow and surges of cold air across the Midwest to the Northeast
- Dental Embed Innovation: An Achievement in Helpful Dentistry
- What we know about the 'Stranger Things' spinoff — plus the one cast member who guessed it correctly
